Effect of 2-methyltaurine and its enantiomers on arterial blood pressure

Pharmacological Research

Volumn 34, Issue 1-2, 1996, Pages 33-36

  Braghiroli, D ^a   Truzzi, C ^a   Brandoli, C ^b   Baraldi, M ^a   Gamberini, G ^a   Di Bella, Maria ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 methyltaurine; Differential scanning calorimetry; Enantiomeric purity; High performance liquid chromatography; Hypotensive activity

Indexed keywords

6 AMINOMETHYL 3 METHYL 4H 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; TAURINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030184026     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0060     Document Type: Article

References (13)

1. 1. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-63.
2. 2. Lambert A, Rose JD. Alkenesulphonic acids: preparation and reactions. J Chem Soc 1949; 46-9.
3. 3. Sgaragli GP, Pavan F. Effects of amino acid compounds injected into cerebrospinal fluid on colonic temperature, arterial blood pressure and behavior of the rat. Neuropharmacology 1972; 11: 45-56.
4. 4. Bousquet P, Feldman J, Bloch R, Schwartz J. Central cardiovascular effects of taurine: comparison with homotaurine and muscimol. J Pharmacol Exp Ther 1981; 219: 213-8.
5. 5. Braghiroli D, Di Bella M, Vaccari G, Baraldi M. Taurine derivatives as potential agents active on taurine transporting system. Fourth Chem Congr North Am, New York, NY, August 25-30, 1991; Abstract MEDI 135.
6. 6. Higashiura K, Morino H, Matsuura H, Toyomaki Y, Ienaga K. Syntheses and properties of optically active 2-substituted taurines. J Chem Soc Perkin Trans I 1989; 1479-81.
7. 7. Jacques J, Collet A, Wilen SH. Experimental aspects and art of resolutions. In: Enantiomers, racemates, and resolutions. New York: John Wiley & Sons, 1981: 378-434.
8. 8. Nimura N, Ogura H, Kinoshita T. Reversed-phase liquid Chromatographic resolution of amino acid enantiomers by derivatization with 2,3,4,6-tetra-Ο-acetyl-β-D-glucopyranosyl isothiocyanate. J Chromatogr 1980; 202: 375-9.
9. 9. Kinoshita T, Kasahara Y, Nimura N. Reversed-phase high-performance liquid Chromatographic resolution of non-esterified enantiomeric amino acids by derivatization with 2,3,4,6-tetra-Ο-acetyl-β-D-glucopyranosyl isothiocyanate and 2,3,4-tri-Ο-acetyl-α-D-arabinopyranosyl isothiocyanate. J Chromatogr 1981; 210: 77-81.
10. 10. Braghiroli D, Di Bella M, Zanoli P, Truzzi C, Baraldi M. Rigid analogs of taurine as potential taurine antagonists. Il Farmaco 1990; 45: 631-45.
11. 11. Bousquet P, Feldman J, Bloch R, Schwartz J. TAG antagonises the central cardiovascular effects of taurine. Eur J Pharmacol 1984; 98: 269-73.
12. 12. Huxtable R, Bressler R. Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta 1973; 323: 573-83.
13. 13. Higashiura K, Kurohashi M. (Nippon Zoki Pharmaceutical Co., Ltd). Jpn Kokai Tokkyo Koho 2115147, 1990 [Chem Abstr 1990; 113: 131569s].